Comparing Three Botulinum Toxins

A study in Plastic and Reconstructive Surgery (May 2016) used digital image correlation to compare dynamic strain reduction between three U.S. Food and Drug Administration (FDA)-approved formulations of botulinum toxin: onabotulinumtoxinA (Botox, Allergan), abobotulinumtoxinA (Dysport, Galderma) and incobotulinumtoxinA (Xeomin, Merz).

The study enrolled 73 treatment-naive women,...

Articles

Comparing Three Botulinum Toxins

A study in Plastic and Reconstructive Surgery (May 2016) used digital image...

Jane Iredale Wins Presidential Award

Iredale Mineral Cosmetics, manufacturer and distributor of Jane Iredale–The Skin Care...

The American Academy of Dermatology (AAD) is accepting applications for two...

Ultrasound for Neck Laxity

In a study published in the Journal of Drugs in Dermatology (May 2016),...

Products

 Gentle Chemical Peel

The SkinLuma Meladec Décolletage Renewal Peel acts on desmosomes—which bind...

 Full Body Hydration

Moisture-Rich Body Crème from EltaMD nourishes, moisturizes, improves skin...

Stabilized Retinol Serum

NeoStrata SKIN ACTIVE Retinol + NAG Complex delivers 0.5% stabilized,...

Body Mapping Software

DermaGraphix 2D body photography software with IntelliStudio from Canfield...

Blogs

Creating Effective Newsletters
By Mara L. Shorr and Jay A. Shorr of Best Medical Business Solutions Each day, your patients’ email inboxes are flooded with e-newsletters and e-blasts craving their attention. Whether they come from daily deal sites, their favorite big box stores or their tried and true online retailers, the sheer...
Setting Expectations for Your Suppliers
By Carol and Rob Trow of Dermaconcepts There are few, if any, more problematic profit issues for aesthetic professionals, practice owners and managers than how to increase retail revenue for their practices. The challenges center on several endemic root causes, which I will discuss below. But it...
Global Consensus on HA Filler Complications

A multinational, multidisciplinary group of experts in cosmetic medicine gathered to develop updated global consensus recommendations for early and late complications associated with clinical uses of Hylacross and Vycross hyaluronic acid (HA) dermal filler products. Their findings were published in Plastic and Reconstructive Surgery

(June 2016).


Massimo Signorini, MD, et al, noted that most HA filler-related complications are mild and transient. Early adverse reactions include vascular infarction and compromise; inflammatory reactions; injection-related events; and inappropriate placement of filler material. Late adverse reactions include nodules, granulomas and skin discoloration. They found that most adverse events can be avoided with proper planning and technique; a detailed understanding of facial anatomy; and proper patient and product selection.


They advise that—because adverse events do occur even with relatively safe products—clinicians must be prepared and have tools available for effective treatment of complications.


Image copyright Getty Images

PicoSure Receives FDA Marketing Clearance for Tattoos and Pigmented Lesions

Laser manufacturer Cynosure has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its PicoSure picosecond laser for the removal of the full spectrum of tattoo inks as well as pigmented lesions.


The device’s new 1064nm wavelength aids in removal of black and other dark tattoo inks and complements the system’s existing 532nm and 755nm wavelengths. It will be offered as an upgrade to existing PicoSure customers, and initial shipments of the new 1064nm laser delivery system are expected to begin in the second half of 2016.


The clinical experience with PicoSure was the subject of 11 oral abstracts and three ePosters during the recent American Society for Laser Medicine & Surgery Annual Conference in Boston. In addition to tattoo removal and skin revitalization, researchers reported on studies evaluating PicoSure as a treatment for melasma.


“PicoSure is widely recognized by aesthetic practitioners for its unsurpassed clinical efficacy and proven performance,” said Michael Davin, CEO of Cynosure. “Consumers simply know it works. With the FDA clearance of the 1064nm Laser Delivery System we believe our picosecond technology has the broadest range of...

Galderma Debuts Mirvaso Dose-Controlled Pump Dispenser

Mirvaso (brimonidine) Topical Gel, 0.33% from Galderma Laboratories is now available in a pump dispenser. Prescription Mirvaso is indicated for the treatment of the persistent facial redness associated with rosacea, and the new pump design was developed to deliver a consistent dose at each use.


“The availability of the Mirvaso Gel Pump offers a number of benefits to patients with facial erythema,” said Sandra Johnson, MD, board certified dermatologist at Johnson Dermatology in Fort Smith, Arkansas, and Galderma consultant. “Research proves that the majority of patients prefer a pump dispenser over a tube. As a frequent prescriber of Mirvaso Gel, I am excited for the introduction of this dosing option that is convenient to use for my patients.”

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.


According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.


The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.


The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »

Cellfina Available in US

Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.


Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »